ARIPRA aripiprazole 10 mg tablet blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

aripiprazole, Quantity: 10 mg

Verfügbar ab:

Medis Pharma Pty Ltd

INN (Internationale Bezeichnung):

aripiprazole

Darreichungsform:

Tablet, uncoated

Zusammensetzung:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; maize starch; hyprolose

Verabreichungsweg:

Oral

Einheiten im Paket:

30

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

Produktbesonderheiten:

Visual Identification: 8mm x 5 mm, capsule shaped, biconvex, white uncoated tablets with 10 debossed on one side and ZL on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2014-10-29